clinical trials

Allogene’s ALLO-501 Shows Positive Results in Its Phase I ALPHA Trial
Allogene’s ALLO-501 Shows Positive Results in Its Phase I ALPHA Trial
BioSpace
Allogene
ASCO 2020
ALLO-501
clinical trials
refractory indolent non-Hodgkins lymphoma
Flag link:
Gilead’s newly bought immunotherapy drug scores at ASCO
Gilead’s newly bought immunotherapy drug scores at ASCO
MedCity News
Gilead Sciences
ASCO 2020
magrolimab
clinical trials
AML
MDS
Flag link:
AstraZeneca bid to expand lung cancer drug's use boosted by trial data
AstraZeneca bid to expand lung cancer drug's use boosted by trial data
BioPharma Dive
AstraZeneca
Tagrisso
lung cancer
clinical trials
ASCO 2020
Flag link:
ASCO: Merck's Keytruda doubles time to disease progression in certain colorectal cancer patients
ASCO: Merck's Keytruda doubles time to disease progression in certain colorectal cancer patients
Fierce Pharma
Merck
Keytruda
clinical trials
ASCO 2020
colorectal cancer
Flag link:
ASCO: Pfizer, Merck KGaA's Bavencio posts win in rare gynecological cancer
ASCO: Pfizer, Merck KGaA's Bavencio posts win in rare gynecological cancer
Fierce Pharma
Pfizer
Merck KGaA
Bavencio
ASCO 2020
bladder cancer
gestational trophoblastic tumors
clinical trials
Flag link:
Roche and Gilead Launch COVID-19 Trial to Test One-Two Punch of Actemra and Remdesivir
Roche and Gilead Launch COVID-19 Trial to Test One-Two Punch of Actemra and Remdesivir
BioSpace
Roche
Gilead Sciences
clinical trials
Actemra
RoActemra
remdesivir
COVID-19
pneumonia
COVID-19 pneumonia
Flag link:
After passing safety hurdle, Orpheris kick-starts COVID-19 cytokine storm efficacy test
After passing safety hurdle, Orpheris kick-starts COVID-19 cytokine storm efficacy test
Fierce Biotech
Orpheris
clinical trials
cytokine storm
COVID-19
OP-101
Flag link:
PhaseBio gets FDA nod to begin Covid-19 trial with VIP receptor agonist PB1046
PhaseBio gets FDA nod to begin Covid-19 trial with VIP receptor agonist PB1046
Pharmaceutical Business Review
PhaseBio
clinical trials
PB1046
COVID-19
Flag link:
Genentech’s Phase III Trial Yields Positive Results and Hope for Patients with Wet AMD
Genentech’s Phase III Trial Yields Positive Results and Hope for Patients with Wet AMD
BioSpace
Genentech
clinical trials
wet age-related macular degeneration
ranibizumab
Flag link:
Dupixent clears PhIII trial in new disease as blockbuster looks to expand past Regeneron-Sanofi split
Dupixent clears PhIII trial in new disease as blockbuster looks to expand past Regeneron-Sanofi split
Endpoints
Dupixent
Sanofi
Regeneron
esosinophilic esophagitis
EoE
clinical trials
Flag link:
Novartis builds case for MS drug ofatumumab as FDA decision looms
Novartis builds case for MS drug ofatumumab as FDA decision looms
Pharmaforum
Novartis
ofatumumab
clinical trials
MS
multiple sclerosis
Flag link:
Ohio Startup Bolstering Supply For Potential COVID-19 Clinical Trial
Ohio Startup Bolstering Supply For Potential COVID-19 Clinical Trial
Forbes
COVID-19
clinical trials
Ohio
Airway Therapeutics
AT-100
Flag link:
He experienced a severe reaction to Moderna’s Covid-19 vaccine candidate. He’s still a believer
He experienced a severe reaction to Moderna’s Covid-19 vaccine candidate. He’s still a believer
Stat
Moderna Therapeutics
clinical trials
patients
vaccines
Flag link:
Oxford Uni coronavirus vaccine ‘has 50% chance of success’
Oxford Uni coronavirus vaccine ‘has 50% chance of success’
Pharmaforum
University of Oxford
vaccines
COVID-19
coronavirus
clinical trials
Flag link:
Novavax Is Beginning Clinical Trials Of Its Coronavirus Vaccine
Novavax Is Beginning Clinical Trials Of Its Coronavirus Vaccine
Forbes
Novavax
clinical trials
Australia
COVID-19
vaccines
Flag link:
FDA Mishaps Have Investors Asking “What’s Going On With bluebird bio?”
FDA Mishaps Have Investors Asking “What’s Going On With bluebird bio?”
Motley Fool
Bluebird Bio
beta thalassemia
LentiGlobin
FDA
pandemic
clinical trials
Flag link:
AstraZeneca's COVID-19 vaccine enters phase 2/3 clinical trial
AstraZeneca's COVID-19 vaccine enters phase 2/3 clinical trial
Fierce Biotech
University of Oxford
AstraZeneca
clinical trials
vaccines
AZD1222
UK
COVID-19
Flag link:
Kadmon’s graft-versus-host disease med on track for 2020 filing
Kadmon’s graft-versus-host disease med on track for 2020 filing
Fierce Biotech
Kadmon
belumodsil
graft vs host disease
clinical trials
Flag link:
ImmunityBio’s Promising Preclinical HIV Drug is Moving into Phase I Trials
ImmunityBio’s Promising Preclinical HIV Drug is Moving into Phase I Trials
BioSpace
ImmunityBio
HIV
clinical trials
N-803
Flag link:
Gilead's filgotinib phase 3 hits primary endpoint but details dampen hopes
Gilead's filgotinib phase 3 hits primary endpoint but details dampen hopes
Fierce Biotech
Gilead Sciences
Galapagos
filgotinib
ulcerative colitis
clinical trials
Flag link:

Pages